These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new treatment era in multiple sclerosis: clinical applications of new concepts. Edan G; Leray E J Neurol Sci; 2011 Jul; 306(1-2):170-2. PubMed ID: 20951999 [TBL] [Abstract][Full Text] [Related]
12. Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies. Kieseier BC; Hartung HP Exp Neurol; 2007 Jan; 203(1):1-4. PubMed ID: 17069803 [No Abstract] [Full Text] [Related]
13. [Multiple sclerosis: new treatment options]. Marziniak M MMW Fortschr Med; 2014 Mar; 156 Spec No 1(1):69-73; quiz 74. PubMed ID: 24930351 [No Abstract] [Full Text] [Related]
14. [EDMUS--a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis"]. Flachenecker P; Hartung HP Nervenarzt; 1996 Apr; 67(4):277-82. PubMed ID: 8684505 [TBL] [Abstract][Full Text] [Related]
15. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo]. Tedeholm H; Skoog B; Hillert J; Runmarker B; Stawiarz L; Oluf A Lakartidningen; 2007 May 30-Jun 3; 104(22):1684-8. PubMed ID: 17601317 [No Abstract] [Full Text] [Related]
16. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Wynn D; Kaufman M; Montalban X; Vollmer T; Simon J; Elkins J; O'Neill G; Neyer L; Sheridan J; Wang C; Fong A; Rose JW; Lancet Neurol; 2010 Apr; 9(4):381-90. PubMed ID: 20163990 [TBL] [Abstract][Full Text] [Related]
17. Interferon beta in multiple sclerosis: how much BENEFIT? Pittock SJ Lancet; 2007 Aug; 370(9585):363-4. PubMed ID: 17678997 [No Abstract] [Full Text] [Related]
18. [Current state of research on multiple sclerosis]. Lubina-Dabrowska N; Stepień A; Chalimoniuk M Pol Merkur Lekarski; 2013 Mar; 34(201):135-9. PubMed ID: 23700821 [TBL] [Abstract][Full Text] [Related]